Clinical Trials Browser

Completed × INDUSTRY × uproleselan × Clear all

NCT04839341 2025-06-27

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02306291 2019-05-17

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute